leisure time -WSS

leisure time

author：focus 2025-09-27 18:53:43 - browse：2618

Novo Nordisk headquarters -- health coverage from STAT — LISELOTTE SABROE/Scanpix/AFP via Getty Images

Fresh off of the news that its drug Wegovy may not just help people lose weight, but could also lower cardiac risks, Novo Nordisk doubled down on its obesity drug pipeline Thursday, acquiring a small Canadian biotech with a new approach to weight loss.

Novo will spend up to $1 billion to buy Inversago Pharma, which is developing an oral obesity drug that targets the cannabinoid receptor CB1. It’s the second big obesity acquisition this year, following Eli Lilly’s move to purchase startup Versanis Bio.

Drugs like Wegovy are in a class called GLP-1 drugs, which mimic the effects of the glucagon-like peptide 1 hormone that help people feel full by targeting the hormone’s receptors.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Kaiser Permanente unions announce official strike date

WSS

Kaiser Permanente unions announce official strike date

Intercept Pharmaceuticals sells itself for less than $1 billion

Intercept Pharmaceuticals sells itself for less than $1 billion

The world needs the new pandemic treaty

Achieving telehealth equity for people with hearing loss

Address the ethical violations that led to 'Three Identical Strangers'

knowledge

leisure time

explore

Wildfire smoke exposes gaps in outdoor worker protections

Data show record exodus of life scientists from academia

Virginia high school admissions case could be legal follow

Why we need mandatory labeling of GMO products

Tori Bowie and the unacceptable rates of Black maternal death

Should insurance cover cosmetic surgery?

At least 13 dead in Texas as scorching temps continue

U.S. death rates show how politics are affecting public health

23andMe had bad news about my health. I wish a person had delivered it

Ozempic cut risk of death in diabetes patients with chronic kidney disease

focus

Why some fertility treatments produce more boy babies

Clinicians often fail to acknowledge the pain caused by long Covid

WHO recommends dropping component of many flu vaccines

Should insurance cover cosmetic surgery?

Covid vaccines: Private market messier than government rollout

Bubonic plague hit France in 1720. Officials dithered. Sound familiar?

knowledge

focus

focus

explore